Constitutive production of multiple cytokines and a human chorionic gonadotrophin β-subunit by a human bladder cancer cell line (KU-19-19): Possible demonstration of totipotential differentiation

British Journal of Cancer

Volumn 76, Issue 2, 1997, Pages 163-174

  Tachibana, M ^a   Miyakawa, A ^a   Nakashima, J ^a   Murai, M ^a   Nakamura, K ^a   Kubo, A ^a   Hata, J I ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Beta human chorionic gonadotrophin; Cytokine expression; Cytokine receptor expression; Haematopoietic growth factors; Human transitional cell carcinoma; Totipotential differentiation

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; CYTOKINE; CYTOKINE RECEPTOR; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CANCER GRADING; CANCER TRANSPLANTATION; CELL DIFFERENTIATION; CELL ULTRASTRUCTURE; CELL VACUOLE; CONTROLLED STUDY; CYTOPLASM; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; HISTOGENESIS; HUMAN; HUMAN CELL; MICROSCOPY; MICROVILLUS; MOUSE; NEUTROPHILIA; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIGHT JUNCTION; TRANSITIONAL CELL CARCINOMA; XENOGRAFT;

EID: 0030986837     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.358     Document Type: Article

References (53)

1. Baldwin GC, Gasson JC, Kaufmann SE, Quan SG, Williams RE, Avalos BR, Gazdar AF, Golde DW and Dipersio J (1989) Nonhenvatopoietic Vumor cells express functional GM-CSF receptors. Blood 73: 1033-1037
2. Benham F, Cottel DC and Franks LM (1977) Alkaline phosphatase activity in human bladder tumor cell lines. J Histochem Cytochem 25: 266-274
3. Berdel WE, Danhauser-Riedl S, Steinhauser G and Winton EF (1989) Various human hematopoietic growth factors (interleukin-3, GM-CSF, G-CSF) stimulate clonal growth of non-hematopoietic tumor cells. Blood 73: 80-83
4. Berdel WE, Danhauser S and Winton EF (1988) Recombinant human granulocyte-macrophage colony stimulating factor stimulates clonogenicity of a human colon tumor cell line in vitro. Exp Hematol 16: 510
5. Bollg W (1994) Experimental basis of cancer combination chemotherapy with retinoids, cytokines, 1,25-dihydroxyvitamin D3, and analogs. J Cell Biochem 56: 427-435
6. Chodak GW and Summerhayes I. (1984) Detection of angiogenesis activity in malignant bladder tissue cells. J Urol 132: 1032-1035
7. Chomozynski P and Sacchi N (1987) Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Chem 162: 156-159
8. Dedhar S, Gaboury L, Galloway P and Eaves C (1988) Human granulocyte-macrophage colony-stimulating factor is a growth factor on a variety of cell types of nonhemutopoielic origin. Proc Natl Acad Sci USA 83: 9253-9257
9. Delwel R, Dorssers L, Toum I, Wagemaker G and L Wenberg B (1987) Human recombinant multilineage colony stimulating factor (interleukin-3): stimulator of acute myelocytic leukemia progenitor cells in vitro. Blood 70: 333-336
10. Demetri GD and Griffin JD (1991) Granulocyte colony-stimulating factor and its receptor. Blood 78: 2791-2808
11. Dexeus F, Logothetis C, Hossan E and Samuels ME (1986) Carcinoembryonic antigen and beta-human chorionic gonadotropin as serum markers for advanced urothelial malignancies. J Urol 136: 403-407
12. Droller MJ, Perlmann P and Schneider MU (1979) Enhancement of natural and antibody-dependent lymphocyte cytotoxicity by drugs which inhibit prostaglandin production by tumor target cells. Cell Immunol 39: 154-164
13. Gasson JC, Kaufman SE, Weisbart RH, Tomonaga M and Golde DW (1986) High-affinity binding of granulocyte-macrophage colony-stimulating factor to normal and leukemic human myeloid cells. Proc Natl Acad Sci USA 83: 669-673
14. Grammaiico D, Grignon DJ, Eberwein P, Shepherd RR, Hearn SA and Walton JC (1993) Transitional cell carcinoma of the renal pelvis with choriocarcinomatous differentiation. Cancer 71: 1835-1841
15. Graffin JD, Young D, Herrmann F, Wiper D, Wagner K and Sabbath KD (1986) Effects of recombinant human GM-CSF on proliferation of clonogenic cells in acute myeloblaslic leukemia. Blood 67: 1448-1453
16. Grawford SM, Ledermann JA, Tuekie W, Rustin GJS, Begent RHJ, Newlands ES and Bagshawre KD (1991) Is ectopic production of human chorionic gonadotrophin (hCG) or alpha fetoprotein (AFP) by tumours a marker of chemosensitivity? Eur J Cancer Clin Oncol 22: 1483-1487
17. Hall RR, Laurence DJR, Neville AM and Wallace DM (1973) Carcinoembryonic antigen and urothelial carcinoma. Br J Urol 45: 88-92
18. Heckl W, Konyar H and Grumine F (1984) Presence of transforming growth factors in human bladder cancer. Proceedings of the European Society of Urology. Oncology and Endocrinology (4th Congress)
19. Hofmann SL (1992) Retinoids 'differentiation agents' for cancer treatment and prevention. Am J Med Sci 304: 202-213
20. Iles RK and Chard T (1991) Human chorionic gonadotropin expression by bladder cancers: biology and clinical potential. J Urol 145: 453-458
21. Kaashoek JGJ, Mout R, Falkenburg JHF, Willemze R, Fibbe WE and Landegent JE (1991) Cytokine production by the bladder carcinoma cell line 5637: rapid analysis of mRNA expression levels using a cDNA-PCR procedure. Lymphokine Cyokine Res 10: 231-235
22. Kawano M, Hirano T, Matsuda T, Taga T, Horii Y, Iwato K, Asaoku H, Tang B, Tanabe O, Tanaka H, Kuramoto A and Kishimoto T (1988) Autocrine generation and requirement of BSF-2/1L-6 for human multiple myelomas. Nature 332: 83-85
23. Kelleher C, Miyauchi J, Wong G, Clark S, Minden MD and McCulloch KA (1987) Synergism between recombinant growth factors, GM-CSF and G-CSF, acting on the blast cells of acute myeloblastic leukemia. Blood 69; 1498-1503
24. Kinjo M, Oka K, Naito S, Konga S, Tanaka K, Oboshi S, Hayata Y and Yasumoto K (1979) Thromboplastic and fibrinolytic activities of cultured human cancer cell lines. Br J Cancer 39: 15-23
25. Messing EM, Hanson P, Ulrich P and Erturk E (1987) Epidermal growth factor-interactions with normal and malignant urothelium: in vivo and in situ studies. J Urol 138: 1329-1335
26. Miki S, Iwano M, Miki V, Yamamoto M, Tang B, Yokokawa K, Sonoda T, Hirano T and Kishimoto T (1989) Interleukin-6 (IL-6) function as an in vitro autocrine growth factor in renal cell carcinomas. FEBS Lett 250: 607-610
27. Mostofi E Sobin LH and Torloni H (1973) InternationalHistological Classification of Tumors, Histological Typing of Urinary Bladder Tumors, No. 10. World Health Organization: Geneva
28. Mulson RA, Gesner TF, Turner K, Norton C, Yang Y-C and Clark S (1997) Characterization of IL-3 receptors on human acute myelogenous leukemia cell line KG-I. Blood 70 (suppl. 1): 181.
29. Neal DE, Smith K, Fennelly JA, Bennett MK, Hall RR and Harris AL (1989) Epidermal growth factor receptor in human bladder cancer: a comparison of immunohistochemistry and ligand binding J Urol 141: 517-521
30. Nicolson GL (1943) Cancer progression and growth: relationship of paracrine and autocrine growth mechanisms to organ preference of metastasis. Exp Cell Res 204: 171 180
31. Oster W, Cicco NA, Klein H, HiranoT, Kishimoto T, Lindemann A, Mertelsmann RH and Herrmann F (1989) Participation of the cytokines interleukin-6. tumor necrosis faclor-α. and interleukin-1α secreted by acute myelogenons leukemia blasts in antocrine and paracrine growth control. J Clin Inrest 84: 451-457
32. Ovejera AA, Houchens DP and Barker AD (1978) Chemotherapy of human tumor xenografts in genetically athymic mice. Ann Clin Lab Sci 8: 50-56
33. Park LS, Friend D, Gillis S and Erdal DL (1986) Charaeterization of the cell surface receptor for human granulocyte/macrophage colony-stimulating factor. J Exp Med 164: 251-262
34. Rosen SW, Weintraub D and Aaronson SA (1980) Nonrandom ectopic protein production by malignant cells: direct evidence in vitro. J Clin Endocrinol Metabol 50: 834-841
35. Rowe JM and Rapoport AP (1992) Hemopoietic growth factors: a review. J Clin Pharmacol 32: 486 501
36. Russell PJ, Raghavan D, Philips J and Wills EJ (1988) The biology of urothelial cancer. In The Management of Bladder Cancer. Raghavan D. (ed.). pp 1 41. Edward Arnold Publishers: Maryland. USA
37. Russell PJ, Wills LJ, Philips J, Wass J. Jelbart M, Gregory P and Raghavan D (1988b) Features of squamous and adenocarinoma in the same cell in a xenografted human transitional cell carcinoma: evidence of a common histogenesis? Urol Res 16: 79-84
38. Russell PJ, Jelbarl M, Wills E, Singh S, Wass J, Wotherspoon J and Raghavan D (1988c) Establishment and characterization of a new human bladder cancel cell line showing features of squamous and glandular differentiation Int J Cancer 41: 74 82
39. Sato K, Terada K, Sugiyama T, Sugiyama T, Masuda H, Kakinuma H and Kato T (1994) Granulocyte colony-stimulating factor produced by bladder carcinoma of a patient with leukemoid reaction did not affect proliferation of the tumor cells. J Urol 151: 1687 1690
40. Serve H, Steinhauser G, Oberberg D, Flegel WA, Northoff H and Berdel W (1991) Studies on the interaction between interleukin 6 and human malignant nonhematopoietic cell lines. Cancer Res 51: 3862-3866
41. Shimamura K, Fujimoto J, Hata J-I, Akatsuka A, ueyama Y, Watanabe T, and Tamaoki N (1990) Establishment of specific monoclonal antibodies against recombinant human granulocyte colony-stimulating factor (hG-CSF) and their application for immunoperoxidase staining of paraffin-embedded sections. J Histochem Cytochem 38: 283-286
42. Sires C, Neely S and Skinner D (1986) Leukemoid reaction in a patient with bladder and prostatic cancer. J Urol 135: 366-367
43. Smith K, Fennelly JA, Neal DE. Hall RR and Harris AL (1989) Characterization and quantitation of the epidermal growth factor receptor in invasive and superficial bladder tumors. Cancer Res 49: 5810-5815
44. Souza LM, Boone TC, Gabrilove J, Lai PH, Zsebo KM, Murdock DC, Chazin VR, Brnszewski J, Lu H, Chen KK, Barendt J, Platzer E, Moore MAS, Mertelsmann R and Weite K (1986) Recombinant human granulocyte colonystimulating. factor: effects on normal and leukemic myeloid cells. Science 232: 61-65
45. Tachibana M (1982) Studies on cellular adhesiveness in five different culture cell lines derived from carcinoma of the bladder. Keio J Med 31: 127 148
46. Tachibana M, Deguchi N, Baba S, Jitsukawa S, Hata M and Tazaki H (1992) Bromodeoxyuridine and deoxyribonucleic acid bivariate analysis in human renal cell carcinoma. Does flow cytometric determination predict malignant potential or prognosis of patients with renal cell carcinoma? Am J Clin pathol 97: s38 47
47. Tomonaga M, Golde DW and Gasson JC (1986) Biosynthetic (recombinant) human granulocyte-macrophage colony-stimulating factor: effects on normal bone marrow and leukemia cell lines. Blood 67: 31-36
48. Vellenga E, Young DC, Wagner K, Wiper D, Ostapoviez D and Griffin JD (1987) The effects of GM-CSF and G-CSF in promoting growth of clonogenic cells in acute myeloblastic leukemia, Biood 69: 1771-1776
49. Welte K, platzar E, Lu L, Gabriloua JL, Levi E, Mertelsmann R and Moore MA (1985) Purification and biochemical characterization of human pluripotent haematopoietic colony-stimulating factor, Proc Acad Sci USA 82: 1526-1530
50. Wetzler M, Estrov Z, Talpaz M, Markowitz A, Gutterman JU and Kurzrock R (1993) Granulocyte-macrophagec colony-stimulation factor as a cause of paraneoplastic leukemoid reaction in advanced transitional cell carcinoma. J Intern Med 234: 413-420
51. Workman P, Balmain A, Hickman JA, McNally NJ, Mitchison NA, Pierrepoint CG, Raymond R, Rowlatt C, Stephens TC and Wallace J (1988) UKCCCR guidelines for the welfare of animals in experimental neoplasia, Br J Cancer 58: 109-113
52. Young DC and Grffin JD (1986) Autocrine secretion of GM-CSF in acute myeloblastic leukemia Blood 68: 1178-1181
53. Zinzor SN, Svet-Moldaveky GJ, Fogh J, Mann PE, Arlin Z, Ilieseu K and Holland JF (1985) Elaboration of granulocyte-macrophage colony-stimulating factor by human tumor cell lines and normal urothelium. Exp Hematol 13: 574-580